Catalyst Funds Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-11,585
Closed -$111K – 680
2025
Q4
$111K Hold
11,585
– – 0.03% 312
2025
Q3
$141K Sell
11,585
-3,800
-25% -$39.9K 0.02% 448
2025
Q2
$123K Sell
15,385
-4,715
-23% -$33.1K 0.03% 338
2025
Q1
$146K Sell
20,100
-19,000
-49% -$138K 0.04% 368
2024
Q4
$269K Buy
39,100
+5,200
+15% +$35.8K 0.07% 224
2024
Q3
$250K Buy
33,900
+30,700
+959% +$287K 0.05% 234
2024
Q2
$33.7K Sell
3,200
-3,840
-55% -$48.7K 0.01% 527
2024
Q1
$97.4K Buy
+7,040
New +$110K 0.03% 400

Other funds holding NUS

Catalyst Funds Management's NUS Position: Q1 2026 in Review

Catalyst Funds Management sold out of Nu Skin (NUS) in Q1 2026, closing a stake of 11,585 shares — an estimated $111K sold.

Catalyst Funds Management first reported a position in NUS in Q1 2024 and held it in 8 quarters. The position peaked at $269K in Q4 2024. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • Catalyst Funds Management reported no remaining Nu Skin position as of Q1 2026 after selling out during the quarter.
  • Catalyst Funds Management sold 11,585 Nu Skin shares in Q1 2026, an estimated $111K.
  • Catalyst Funds Management first reported a position in Nu Skin in Q1 2024 and held it in 8 quarters.
  • Catalyst Funds Management's Nu Skin position peaked at $269K in Q4 2024.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.